Azurion 7 M20
Payments companies reported to CMS as associated with Azurion 7 M20. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Azurion 7 M20, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Azurion 7 M20
These are the largest totals companies reported as associated with Azurion 7 M20. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Abraham Levitin | Cleveland, OH | Diagnostic Radiology | $1,712.50 |
| Karunakaravel Karuppasamy | Cleveland, OH | Diagnostic Radiology | $1,561.69 |
| Jaikirshan Khatri | New York, NY | Interventional Cardiology | $1,472.98 |
| Michael Workman | Springfield, MO | Neuroradiology | $1,299.69 |
| Anand Dayama | Sioux Falls, SD | Vascular Surgery | $1,201.64 |
| Raja Ramaswamy | Indianapolis, IN | Diagnostic Radiology | $1,038.72 |
| Chirdeep Patel | Allentown, PA | Interventional Cardiology | $756.44 |
| Eric Elgin | Allentown, PA | Interventional Cardiology | $747.06 |
| Roger Williams | Marietta, GA | Vascular & Interventional Radiology | $743.10 |
| Timothy Misselbeck | Allentown, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $646.87 |
Prescribed Azurion 7 M20?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.